<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03972878</url>
  </required_header>
  <id_info>
    <org_study_id>FP-1.0</org_study_id>
    <nct_id>NCT03972878</nct_id>
  </id_info>
  <brief_title>Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products</brief_title>
  <acronym>FP1</acronym>
  <official_title>Foodprint 1.0: Metabolic, Hormonal, Inflammatory and Oxidative Post-prandial Responses After Consumption of Confectionary Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The composition of a food or a meal consumed plays an important role in the rate of
      postprandial endocrine and metabolic response, especially if high in fats, sugars and total
      energy content and a reduction in its entity is related to beneficial effects towards the
      prevention of several chronical diseases. The physiological postprandial response depends on
      several factors, both intrinsic, such as natural characteristic of food, and extrinsic, such
      as the way in which food is processed. This study aims at investigating postprandial
      hormonal, metabolic, oxidative stress, inflammation and endotoxaemia responses after the
      consumption of different commercial confectionary products made with different reformulation
      (ingredients and/or processing techniques).The principal scope of the study is to evaluate
      the impact of the reformulation of different snacks on postprandial responses. The
      investigators therefore designed a randomized controlled crossover trial, in which 15 healthy
      volunteers will consume different isocaloric confectionary products (snacks) and their
      related reformulation (total products number = 6) and a reference snack. Venous blood samples
      will be collected until 4-h after meal consumption. In order to evaluate postprandial
      hormonal, metabolic, oxidative stress, inflammation and endotoxaemia responses several
      markers will be evaluate:

        -  metabolic substrates: glucose; Triglycerides and NEFA;

        -  hormones: insulin; c-peptide; GLP-1, GIP, leptin, ghrelin, PYY;

        -  markers of inflammation: IL-6, IL-8, IL-10, IL-17, TNF-α, hsCRP, MCP-1;

        -  markers of oxidative stress and antioxidant capacity: GSH, FRAP;

        -  endotoxaemia: lipopolysaccharides (LPS).

      These results will contribute to a detailed evaluation of the effects of reformulation on
      physiological events after meal consumption, leading to clarify if these variations in
      ingredients and/or processing techniques can modify postprandial responses, making them more
      similar to those originated from the reference snack.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Meal consumption, especially if high in fats, sugars and total energy content, leads to a
      transient rise in blood glucose and lipids. The extent of glycemic and lipidemic postprandial
      responses have been linked to the progression of cardiovascular and other chronic
      degenerative diseases, such as type 2 diabetes and Alzheimer through a substantial increase
      in oxidative stress, systemic inflammation, and endothelial dysfunction. In addition, some
      studies have shown that consuming a high fat meal is associated with a postprandial increase
      in plasma and serum endotoxin concentrations in humans. LPS, lipopolysaccharide, is
      considered a major predisposing factor for inflammation-associated diseases such as
      atherosclerosis, sepsis and obesity. Therefore, following a correct dietary model may be
      beneficial in order to limit postprandial excursion and to modulate hormonal responses
      involved in satiety.

      The physiological postprandial response depends on several factors, both intrinsic, such as
      natural characteristic of food, and extrinsic, such as the way in which food is processed.
      Thus, the present study aims at evaluating if the reformulation of some commercial
      confectionery products can lead to an improvement of the nutritional profile, through a
      decrease of postprandial metabolic and hormonal, oxidative stress, inflammation and
      endotoxaemia responses in comparison with commercial confectionery products (snacks).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 22, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study is a cross-over, randomized intervention trial. Each subject consumed in a randomly order seven foods test with a one-week wash out between different treatments. The portion size of each foods test was calculated in order to provide the same calories.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IAUC postprandial blood glucose</measure>
    <time_frame>0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes</time_frame>
    <description>Incremental area under the curve of blood glucose postprandial response (IAUC)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial response for blood glucose</measure>
    <time_frame>0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes</time_frame>
    <description>incremental blood glucose concentration at each timepoint of the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IAUC postprandial blood hormones (insulin, c-peptide, ghrelin, Glucagon-like peptide 1 (GLP-1), Gastric inhibitory peptide (GIP), peptide YY (PYY), leptin)</measure>
    <time_frame>0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes</time_frame>
    <description>Incremental area under the curve for blood insulin postprandial response (IAUC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial response for blood hormones (insulin, c-peptide, ghrelin, Glucagon-like peptide 1 (GLP-1), Gastric inhibitory peptide (GIP), peptide YY (PYY), leptin)</measure>
    <time_frame>0 (fasting), 15, 30, 45, 60, 90, 120, 180, 240 minutes</time_frame>
    <description>incremental blood insulin concentration at each timepoint of the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IAUC postprandial blood lipids triglycerides (TAG) and non esterified fatty acid (NEFA)</measure>
    <time_frame>0 (fasting), 30, 60, 90, 120, 180, 240 minutes</time_frame>
    <description>Incremental area under the curve for blood TAG and NEFA postprandial response (IAUC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial response for blood lipids triglycerides (TAG) and non esterified fatty acid (NEFA)</measure>
    <time_frame>0 (fasting), 30, 60, 90, 120, 180, 240 minutes</time_frame>
    <description>incremental blood TAG and NEFA concentration at each timepoint of the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IAUC postprandial blood inflammatory markers (IL-6, IL-8, IL-10, IL-17, TNF-α, hsCRP, MCP-1)</measure>
    <time_frame>0 (fasting), 60, 90, 120, 180, 240 minutes</time_frame>
    <description>Incremental area under the curve for blood inflammatory markers (IL-6, IL-8, IL-10, IL-17, TNF-α, hsCRP, MCP-1) postprandial response (IAUC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial response for blood inflammatory markers (IL-6, IL-8, IL-10, IL-17, TNF-α, hsCRP, MCP-1)</measure>
    <time_frame>0 (fasting), 60, 90, 120, 180, 240 minutes</time_frame>
    <description>incremental blood inflammatory markers (IL-6, IL-8, IL-10, IL-17, TNF-α, hsCRP, MCP-1) concentration at each timepoint of the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IAUC postprandial blood oxidative stress related markers glutathione (GSH) and antioxidant capacity (Ferric ion reducing antioxidant power (FRAP))</measure>
    <time_frame>0 (fasting), 60, 90, 120, 180, 240 minutes</time_frame>
    <description>Incremental area under the curve for blood oxidative stress related markers glutathione (GSH) and antioxidant capacity (Ferric ion reducing antioxidant power (FRAP))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial response for blood oxidative stress related markers glutathione (GSH) and antioxidant capacity (Ferric ion reducing antioxidant power (FRAP))</measure>
    <time_frame>0 (fasting), 60, 90, 120, 180, 240 minutes</time_frame>
    <description>incremental blood oxidative stress related markers glutathione (GSH) and antioxidant capacity (Ferric ion reducing antioxidant power (FRAP)) concentration at each timepoint of the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IAUC postprandial blood endotoxemia (Lipopolysaccharides (LPS))</measure>
    <time_frame>0 (fasting), 60, 90, 120, 180, 240 minutes</time_frame>
    <description>Incremental area under the curve for LPS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial response for blood LPS</measure>
    <time_frame>0 (fasting), 60, 90, 120, 180, 240 minutes</time_frame>
    <description>incremental blood LPS concentration at each timepoint of the curve</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postprandial satiety using a 100mm visual analog scale</measure>
    <time_frame>0 (fasting), 15, 30, 60, 120, 240 minutes</time_frame>
    <description>Differences in subject-rated satiety using a 100mm visual analog scale (centimeter) Range 0-10 centimeter. Higher are the values of satiety in each timepoints better is the product.</description>
  </other_outcome>
  <other_outcome>
    <measure>Palatability</measure>
    <time_frame>12 minutes (after consumption)</time_frame>
    <description>Palatability using a 100mm visual analog scale (centimeter). Range 0-10 centimeter. Higher is the value of palatability better is the product.</description>
  </other_outcome>
  <other_outcome>
    <measure>Postprandial gastrointestinal symptoms using a 100mm visual analog scale</measure>
    <time_frame>0 (fasting), 15, 30, 60, 120, 240 minutes</time_frame>
    <description>gastrointestinal symptoms using a 100mm visual analog scale (centimeter). range 0-10 centimeter. Lower are the values of gastrointestinal symptoms better is the product.</description>
  </other_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Glucose, High Blood</condition>
  <condition>Inflammatory Response</condition>
  <condition>Oxidative Stress</condition>
  <condition>Endotoxemia</condition>
  <arm_group>
    <arm_group_label>control snack</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control snack</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control cream</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>control spreadable cream</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cream version 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>control spreadable cream, version 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cream version 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>control spreadable cream, version 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cream version 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>control spreadable cream, version 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control chocolate bar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>control chocolate bar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>chocolate bar version 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>control chocolate bar version 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control snack</intervention_name>
    <description>dry fruit snack (200 kcal) + 250 ml water</description>
    <arm_group_label>control snack</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control cream</intervention_name>
    <description>commercial spreadable cocoa and hazelnut cream (200 kcal)+ 250 ml water</description>
    <arm_group_label>control cream</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cream version 1</intervention_name>
    <description>commercial spreadable cocoa and hazelnut cream (200 kcal), version 1+ 250 ml water</description>
    <arm_group_label>cream version 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cream version 2</intervention_name>
    <description>commercial spreadable cocoa and hazelnut cream (200 kcal), version 2+ 250 ml water</description>
    <arm_group_label>cream version 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cream version 3</intervention_name>
    <description>commercial spreadable cocoa and hazelnut cream (200 kcal), version 3+ 250 ml water</description>
    <arm_group_label>cream version 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control chocolate bar</intervention_name>
    <description>commercial chocolate bar (200 kcal)+ 250 ml water</description>
    <arm_group_label>control chocolate bar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>chocolate bar version 1</intervention_name>
    <description>commercial chocolate bar (200 kcal), version 1+ 250 ml water</description>
    <arm_group_label>chocolate bar version 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Healthy male and female adult subjects

        Exclusion Criteria:

          -  BMI &gt; 30 kg/m2

          -  Metabolic disorders (diabetes, hypertension, dyslipidemia, glucidic intolerance)

          -  Chronic drug therapies for any pathologies (including psychiatric diseases)

          -  Dietary supplements affecting metabolism of glucose and lipid

          -  Celiac disease

          -  Pregnancy or lactation

          -  Lactose intolerance

          -  Food allergies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Parma</name>
      <address>
        <city>Parma</city>
        <zip>43125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Emerson SR, Kurti SP, Harms CA, Haub MD, Melgarejo T, Logan C, Rosenkranz SK. Magnitude and Timing of the Postprandial Inflammatory Response to a High-Fat Meal in Healthy Adults: A Systematic Review. Adv Nutr. 2017 Mar 15;8(2):213-225. doi: 10.3945/an.116.014431. Print 2017 Mar. Review.</citation>
    <PMID>28298267</PMID>
  </reference>
  <reference>
    <citation>Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007 Nov;86(5):1286-92.</citation>
    <PMID>17991637</PMID>
  </reference>
  <reference>
    <citation>Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res. 2014 Jan;58(1):136-46. doi: 10.1002/mnfr.201300104. Epub 2013 Jul 12. Review.</citation>
    <PMID>23847095</PMID>
  </reference>
  <reference>
    <citation>O'Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol. 2007 Sep 1;100(5):899-904. Epub 2007 Jun 26. Review.</citation>
    <PMID>17719342</PMID>
  </reference>
  <reference>
    <citation>Treib J, Haass A, Kiessig ST, Woessner R, Grauer MT, Schimrigk K. Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence. Infection. 1996 Sep-Oct;24(5):400-2.</citation>
    <PMID>8923057</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 31, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2019</study_first_posted>
  <last_update_submitted>April 2, 2020</last_update_submitted>
  <last_update_submitted_qc>April 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Parma</investigator_affiliation>
    <investigator_full_name>Daniele Del Rio</investigator_full_name>
    <investigator_title>Professor of Nutrition at Department of Veterinary Science, University of Parma</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endotoxemia</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

